FDA Inspection 1321532 — Rhode Island Blood Center, a Division of New York Blood Center, Inc. Aquidneck Island Donor Center
The FDA completed an inspection of Rhode Island Blood Center, a Division of New York Blood Center, Inc. Aquidneck Island Donor Center on May 12, 2026 in Middletown, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 12, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Middletown, RI (United States)